Clinical Trial Update: A Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating RO5429083 alone or in combination with cytarabine in patients with acute myeloid leukemia. The study status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• RO5429083

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Myelogenous Leukemia, Acute | Phase 1 | Status: COMPLETED